New COVID-19 Cases Remain in the 30,000s for Four Days... Home Treatment Patients Near 160,000

Fatality Rate 0.64% ... Confirmed Cases Increasing but Deaths and Severe Cases Remain Stable

[Asia Economy Reporter Ki Ha-young] The number of new COVID-19 cases has exceeded 30,000 for four consecutive days, continuing the spread driven by the Omicron variant.

The Central Disease Control Headquarters announced that as of midnight on the 8th, the number of new confirmed cases increased by 36,719 from the previous day, bringing the total to 1,081,681. The number of new cases rose by 1,433 from the previous day (35,286), marking four consecutive days above 30,000.

However, this has not yet led to an increase in deaths or critically ill patients. The number of critically ill patients on this day was 268, two fewer than the previous day. Deaths increased by 36, totaling 6,922. The fatality rate stands at 0.64%.

Unlike critically ill patients, the number of asymptomatic and mild cases is rapidly increasing, with 159,169 patients under home treatment as of midnight, an increase of 12,724 from the previous day.

Regarding the infection routes of new confirmed cases, 36,619 were locally transmitted. Among local cases, Gyeonggi reported 12,123, Seoul 5,901, and Incheon 2,976, with 21,000 cases (57.3%) coming from the metropolitan area alone. In non-metropolitan areas, there were 1,918 in Busan, 1,894 in Gyeongnam, 1,788 in Daegu, 1,543 in Gyeongbuk, 1,401 in Chungnam, 1,237 in Gwangju, 1,225 in Jeonbuk, 1,015 in Jeonnam, 940 in Daejeon, 796 in Chungbuk, 736 in Gangwon, 501 in Ulsan, 382 in Jeju, and 243 in Sejong, totaling 15,619 cases (42.7%). The number of imported cases was 100.

Due to the spread of the Omicron variant, the number of new confirmed cases is rapidly increasing. Over the past week from the 2nd, the daily new cases were 20,268 → 22,907 → 27,438 → 36,346 → 38,689 → 35,286 → 36,719, averaging about 31,093 cases per day.

Meanwhile, 55.4% of the total population (a cumulative 28,424,875 people) have completed the third dose of the COVID-19 vaccine.

This content was produced with the assistance of AI translation services.